Respiratory Solutions

Description

The Framework Agreement is for the supply of Respiratory Solutions products including, Oxygen therapy, aerosol therapy, resuscitation therapy, anaesthesia and resuscitation, diagnostics and sterile water and humidification. Precise quantities are unknown. It is anticipated that initial expenditure will be circa £14,741,609 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Estimated total value will be circa 60,759,134 (2+2 year term).